跳至主要内容
临床试验/JPRN-UMIN000019168
JPRN-UMIN000019168已完成未知

Plasma and urinary concentrations of 5-aminolevulinic acid (5-ALA) and its metabolites after oral administration of 5-ALA hydrochloride in healthy subjects. - Plasma and urinary concentrations of 5-aminolevulinic acid (5-ALA) and its metabolites after oral administration of 5-ALA hydrochloride in healthy subjects.

Hiroshima University0 个研究点目标入组 120 人开始时间: 2015年10月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 79years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) History of cancer diagnosis 2) Participation in any clinical trial within 90 days of the commencement of the trial 3) Pregnant or nursing a child 4) Cardiac, renal, and/or hepatic dysfunction 5) History of severe disease and/or major surgery 6) History of hypersensitivity caused by 5-aminolevulinic acid or porphyrin 7) Porphyria 8) Severe anemia 9) Taking drugs or functional food that may cause photosensitivity (e.g. tetracycline antibiotics, sulfonamides, new quinolone antibacterial agents, Hypericum perforatum, and so on)

研究者

相似试验